INFI Annual CFO
-$42.43 M
-$1.81 M-4.46%
31 December 2022
Summary:
As of January 21, 2025, INFI annual cash flow from operations is -$42.43 million, with the most recent change of -$1.81 million (-4.46%) on December 31, 2022. During the last 3 years, it has fallen by -$901.00 thousand (-2.17%).INFI Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly CFO
-$8.01 M
+$4.57 M+36.33%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly cash flow from operations is -$8.01 million, with the most recent change of +$4.57 million (+36.33%) on June 30, 2023. Over the past year, it has increased by +$2.59 million (+24.43%).INFI Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI TTM CFO
-$38.88 M
+$2.59 M+6.24%
30 June 2023
Summary:
As of January 21, 2025, INFI TTM cash flow from operations is -$38.88 million, with the most recent change of +$2.59 million (+6.24%) on June 30, 2023. Over the past year, it has increased by +$2.83 million (+6.78%).INFI TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.5% | +24.4% | +6.8% |
| 3 y3 years | -2.2% | -5.8% | -2.2% |
| 5 y5 years | -15.6% | -65.9% | +6.4% |
INFI Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -136.0% | -103.4% | -130.3% |
Infinity Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$8.01 M(-36.3%) | -$38.88 M(-6.2%) |
| Mar 2023 | - | -$12.58 M(+41.3%) | -$41.47 M(-2.3%) |
| Dec 2022 | -$42.43 M(+4.5%) | -$8.90 M(-5.3%) | -$42.43 M(-1.9%) |
| Sept 2022 | - | -$9.40 M(-11.3%) | -$43.25 M(+3.7%) |
| June 2022 | - | -$10.60 M(-21.7%) | -$41.71 M(+2.5%) |
| Mar 2022 | - | -$13.54 M(+39.3%) | -$40.68 M(+0.2%) |
| Dec 2021 | -$40.62 M(+13.7%) | -$9.72 M(+23.6%) | -$40.62 M(+3.1%) |
| Sept 2021 | - | -$7.86 M(-17.8%) | -$39.41 M(-0.1%) |
| June 2021 | - | -$9.57 M(-29.0%) | -$39.43 M(+5.3%) |
| Mar 2021 | - | -$13.47 M(+58.3%) | -$37.43 M(+4.7%) |
| Dec 2020 | -$35.74 M(-13.9%) | -$8.51 M(+8.0%) | -$35.74 M(-1.0%) |
| Sept 2020 | - | -$7.88 M(+4.1%) | -$36.10 M(-5.1%) |
| June 2020 | - | -$7.57 M(-35.7%) | -$38.04 M(+1.1%) |
| Mar 2020 | - | -$11.78 M(+32.7%) | -$37.63 M(-9.4%) |
| Dec 2019 | -$41.53 M(+781.0%) | -$8.88 M(-9.6%) | -$41.53 M(+154.8%) |
| Sept 2019 | - | -$9.82 M(+37.1%) | -$16.30 M(+21.0%) |
| June 2019 | - | -$7.16 M(-54.3%) | -$13.47 M(+21.0%) |
| Mar 2019 | - | -$15.68 M(-195.8%) | -$11.13 M(+136.2%) |
| Dec 2018 | -$4.71 M(-87.2%) | $16.36 M(-334.0%) | -$4.71 M(-76.3%) |
| Sept 2018 | - | -$6.99 M(+44.9%) | -$19.86 M(-16.9%) |
| June 2018 | - | -$4.83 M(-47.9%) | -$23.91 M(-17.0%) |
| Mar 2018 | - | -$9.26 M(-866.1%) | -$28.79 M(-21.6%) |
| Dec 2017 | -$36.71 M(-76.2%) | $1.21 M(-110.9%) | -$36.71 M(-37.7%) |
| Sept 2017 | - | -$11.04 M(+13.7%) | -$58.89 M(-29.0%) |
| June 2017 | - | -$9.71 M(-43.5%) | -$82.94 M(-30.7%) |
| Mar 2017 | - | -$17.18 M(-18.1%) | -$119.66 M(-22.5%) |
| Dec 2016 | -$154.36 M(+84.5%) | -$20.97 M(-40.2%) | -$154.36 M(+204.9%) |
| Sept 2016 | - | -$35.09 M(-24.4%) | -$50.62 M(+0.3%) |
| June 2016 | - | -$46.43 M(-10.5%) | -$50.45 M(+40.7%) |
| Mar 2016 | - | -$51.87 M(-162.7%) | -$35.87 M(-57.1%) |
| Dec 2015 | -$83.65 M(-171.1%) | $82.77 M(-337.0%) | -$83.65 M(-60.8%) |
| Sept 2015 | - | -$34.92 M(+9.6%) | -$213.40 M(-457.1%) |
| June 2015 | - | -$31.84 M(-68.0%) | $59.76 M(-3.0%) |
| Mar 2015 | - | -$99.66 M(+112.1%) | $61.61 M(-47.7%) |
| Dec 2014 | $117.72 M(-203.3%) | -$46.98 M(-119.7%) | $117.72 M(-8.2%) |
| Sept 2014 | - | $238.24 M(-894.4%) | $128.23 M(-194.0%) |
| June 2014 | - | -$29.99 M(-31.1%) | -$136.40 M(+3.2%) |
| Mar 2014 | - | -$43.55 M(+19.4%) | -$132.16 M(+16.0%) |
| Dec 2013 | -$113.91 M(+42.1%) | -$36.47 M(+38.2%) | -$113.91 M(+0.3%) |
| Sept 2013 | - | -$26.39 M(+2.5%) | -$113.53 M(-3.4%) |
| June 2013 | - | -$25.75 M(+1.8%) | -$117.54 M(+24.7%) |
| Mar 2013 | - | -$25.30 M(-29.9%) | -$94.22 M(+17.6%) |
| Dec 2012 | -$80.14 M(+142.0%) | -$36.09 M(+18.7%) | -$80.14 M(+52.3%) |
| Sept 2012 | - | -$30.40 M(+1150.6%) | -$52.60 M(+80.6%) |
| June 2012 | - | -$2.43 M(-78.3%) | -$29.12 M(-17.2%) |
| Mar 2012 | - | -$11.21 M(+31.1%) | -$35.19 M(+6.3%) |
| Dec 2011 | -$33.11 M | -$8.55 M(+23.5%) | -$33.11 M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$6.92 M(-18.5%) | -$33.02 M(-6.1%) |
| June 2011 | - | -$8.49 M(-7.1%) | -$35.17 M(+8.0%) |
| Mar 2011 | - | -$9.14 M(+7.9%) | -$32.57 M(+22.5%) |
| Dec 2010 | -$26.59 M(+458.9%) | -$8.47 M(-6.7%) | -$26.58 M(-0.3%) |
| Sept 2010 | - | -$9.07 M(+53.9%) | -$26.67 M(-0.1%) |
| June 2010 | - | -$5.89 M(+87.1%) | -$26.70 M(+14.4%) |
| Mar 2010 | - | -$3.15 M(-63.2%) | -$23.33 M(+390.5%) |
| Dec 2009 | -$4.76 M(-54.4%) | -$8.55 M(-6.1%) | -$4.76 M(-117.1%) |
| Sept 2009 | - | -$9.11 M(+260.8%) | $27.88 M(+20.9%) |
| June 2009 | - | -$2.52 M(-116.4%) | $23.06 M(+49.6%) |
| Mar 2009 | - | $15.43 M(-36.0%) | $15.41 M(-247.9%) |
| Dec 2008 | -$10.42 M(-186.3%) | $24.09 M(-272.9%) | -$10.42 M(-72.0%) |
| Sept 2008 | - | -$13.94 M(+37.0%) | -$37.21 M(+24.2%) |
| June 2008 | - | -$10.17 M(-2.3%) | -$29.95 M(+20.1%) |
| Mar 2008 | - | -$10.41 M(+286.4%) | -$24.94 M(-306.4%) |
| Dec 2007 | $12.08 M(+25.1%) | -$2.69 M(-59.7%) | $12.08 M(+78.9%) |
| Sept 2007 | - | -$6.68 M(+29.4%) | $6.75 M(-81.6%) |
| June 2007 | - | -$5.16 M(-119.4%) | $36.69 M(+14.2%) |
| Mar 2007 | - | $26.61 M(-431.7%) | $32.13 M(+232.7%) |
| Dec 2006 | $9.66 M(-134.6%) | -$8.02 M(-134.5%) | $9.66 M(-6.3%) |
| Sept 2006 | - | $23.26 M(-339.2%) | $10.31 M(-127.8%) |
| June 2006 | - | -$9.73 M(-334.8%) | -$37.11 M(+24.6%) |
| Mar 2006 | - | $4.14 M(-156.2%) | -$29.77 M(+6.7%) |
| Dec 2005 | -$27.89 M(-5.4%) | -$7.37 M(-69.5%) | -$27.89 M(-47.3%) |
| Sept 2005 | - | -$24.15 M(+910.8%) | -$52.90 M(+93.5%) |
| June 2005 | - | -$2.39 M(-139.7%) | -$27.34 M(+14.5%) |
| Mar 2005 | - | $6.02 M(-118.6%) | -$23.88 M(-19.0%) |
| Dec 2004 | -$29.47 M(-445.9%) | -$32.38 M(-2407.0%) | -$29.47 M(-560.8%) |
| Sept 2004 | - | $1.40 M(+30.9%) | $6.40 M(+18.2%) |
| June 2004 | - | $1.07 M(+148.3%) | $5.41 M(-3.4%) |
| Mar 2004 | - | $431.70 K(-87.6%) | $5.60 M(-34.2%) |
| Dec 2003 | $8.52 M(-499.1%) | $3.49 M(+733.8%) | $8.52 M(+33.7%) |
| Sept 2003 | - | $418.50 K(-66.9%) | $6.37 M(+157.6%) |
| June 2003 | - | $1.26 M(-62.2%) | $2.47 M(+274.2%) |
| Mar 2003 | - | $3.35 M(+149.1%) | $661.30 K(-131.0%) |
| Dec 2002 | -$2.13 M(+39.7%) | $1.34 M(-138.6%) | -$2.13 M(-48.8%) |
| Sept 2002 | - | -$3.48 M(+534.6%) | -$4.17 M(-266.6%) |
| June 2002 | - | -$548.50 K(-199.5%) | $2.50 M(-1488.6%) |
| Mar 2002 | - | $551.00 K(-180.2%) | -$180.00 K(-88.2%) |
| Dec 2001 | -$1.53 M(-144.1%) | -$686.70 K(-121.6%) | -$1.53 M(-153.4%) |
| Sept 2001 | - | $3.18 M(-198.6%) | $2.86 M(+231.6%) |
| June 2001 | - | -$3.23 M(+305.0%) | $862.70 K(-78.1%) |
| Mar 2001 | - | -$797.00 K(-121.5%) | $3.94 M(+13.8%) |
| Dec 2000 | $3.46 M(-160.4%) | $3.70 M(+212.4%) | $3.46 M(-1558.2%) |
| Sept 2000 | - | $1.19 M(-905.8%) | -$237.60 K(-83.3%) |
| June 2000 | - | -$147.10 K(-88.5%) | -$1.42 M(+11.5%) |
| Mar 2000 | - | -$1.28 M | -$1.28 M |
| Dec 1999 | -$5.74 M | - | - |
FAQ
- What is Infinity Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual CFO year-on-year change?
- What is Infinity Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly CFO year-on-year change?
- What is Infinity Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals TTM CFO year-on-year change?
What is Infinity Pharmaceuticals annual cash flow from operations?
The current annual CFO of INFI is -$42.43 M
What is the all time high annual CFO for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual cash flow from operations is $117.72 M
What is Infinity Pharmaceuticals annual CFO year-on-year change?
Over the past year, INFI annual cash flow from operations has changed by -$1.81 M (-4.46%)
What is Infinity Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of INFI is -$8.01 M
What is the all time high quarterly CFO for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly cash flow from operations is $238.24 M
What is Infinity Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, INFI quarterly cash flow from operations has changed by +$2.59 M (+24.43%)
What is Infinity Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of INFI is -$38.88 M
What is the all time high TTM CFO for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high TTM cash flow from operations is $128.23 M
What is Infinity Pharmaceuticals TTM CFO year-on-year change?
Over the past year, INFI TTM cash flow from operations has changed by +$2.83 M (+6.78%)